Cancer Registry Software Market Top Companies Study - Elekta (Sweden), Electronic Registry Systems, Inc. (US), Onco, Inc. (US), C/NET Solutions (US), Rocky Mountain Cancer Data Systems (US).

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cancer Registry Software Market- (By Software Type (Standalone Software, Integrated Software), By Database (Public data, Commercial data), By Deployment Model (Cloud-based, On-premises), By Functionality (Cancer reporting to meet federal regulations, Patient care management, Product outcome evaluation, Medical research and clinical studies), By End-User (Government organisation and third-party administrator, Hospitals and medical practices, Research centres, Pharmaceutical, Biotechnology companies & medical device companies, Private players, Research centres)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Cancer Registry Software Market is valued at US$ 76.07 Mn in 2022, and it is expected to reach US$ 181.84 Mn by 2031, with a CAGR of 10.3% during a forecast period of 2023-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1992

Cancer registries play a critical role in supporting clinical research and improving patient care. Most countries utilize population-based and hospital-based cancer registries to monitor and manage cancer cases. Population-based registries, established by government agencies, aim to achieve key objectives such as early cancer detection, understanding cancer trends, prevention strategies, and analyzing treatment patterns and prognosis. These registries provide a cost-effective means of evaluating cancer prevention programs, thereby reducing the cancer burden in various regions. The increasing global demand for effective cancer control has led to a significant rise in the number of cancer registries.

Market growth is expected to be driven by several factors, including the rising prevalence of cancer, improvements in healthcare quality, reduction in healthcare costs, and strategic initiatives by key market players such as new product and service launches, as well as mergers and acquisitions. The introduction of efficient and cost-effective digital solutions is enhancing infrastructure and reducing operational expenses, which is anticipated to further drive market expansion. However, concerns surrounding patient data security and privacy are expected to restrain market growth. Additionally, the limited adoption of advanced software solutions by certain healthcare facilities may pose a challenge to market development.

Furthermore, both government and private cancer registries are contributing to the advancement of sophisticated cancer registry software and improving data quality. Research institutions and pharmaceutical companies are increasingly relying on cancer registries as a valuable resource for follow-up data during Phase III and IV clinical trials. Enhanced clinical research and healthcare evaluation are expected to reduce the overall cancer burden, thereby accelerating market growth over the forecast period.

List of Prominent Players in the Cancer Registry Software Market:
• Elekta (Sweden),
• Electronic Registry Systems, Inc. (US),
• Onco, Inc. (US),
• C/NET Solutions (US),
• Rocky Mountain Cancer Data Systems (US),
• McKesson Corporation (US)

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03

Market Dynamics:
Drivers:
The cancer registry software market is experiencing rapid growth, driven by increasing efforts to enhance healthcare infrastructure and reduce the costs associated with delivering healthcare services. The market is also benefiting from various government-led initiatives aimed at reducing cancer incidence and the high adoption rate of cancer registry software. The rising prevalence of cancer, one of the most common chronic diseases and a leading cause of mortality, is a key factor fueling market expansion. Contributing factors to the increasing incidence of cancer include dietary changes, environmental factors such as pollution and tobacco consumption, and genetic mutations. The growing global prevalence of these factors has significantly contributed to cancer becoming the second leading cause of death worldwide.

Challenges:
A major challenge facing the global cancer registry software market is the lack of interoperability among systems. Cancer registries play a crucial role in improving patient care by providing accurate and accessible information on patients, their treatments, and clinical outcomes. However, the widespread use of multiple electronic health record (EHR) systems by hospitals and cancer centers often leads to inefficiencies in clinical workflows. Direct integration of cancer registries with EHR systems remains a significant challenge, as the inability to seamlessly extract data from cancer registries may limit the demand for registry software. This interoperability issue is expected to constrain market growth during the forecast period.

Regional Trends:
The North American cancer registry software market is expected to secure a significant market share, driven by new product launches and the rising incidence of chronic diseases such as cancer. Increased adoption of cancer registries is anticipated to further drive market growth. Many cancer registries have adopted Registry Plus products as their standard operating system due to their ability to support compliance with the National Program of Cancer Registries (NPCR) electronic data-sharing requirements while enhancing the efficiency of registry operations. High adoption rates are likely to stimulate market expansion in the near term.

Similarly, the Asia-Pacific region is projected to hold a substantial market share due to factors such as a growing population, rapid urbanization, and increasing industrialization. Furthermore, research and development (R&D) activities by leading industry players are expected to contribute to market growth in the region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1992

Recent Developments:
• In Sept 2022, Nursenav Inc. and Electronic Registry Systems (ERS) Inc. collaborated to connect their two most prominent software products, CRStar and CONNECT. In order to complement the services offered by oncology navigation, this integration made use of cancer registry workflows and data collecting.
• In December 2020, McKesson started Ontada, an oncology technology and insights business that aims to help improve cancer research and care. Ontada was in a unique situation to improve cancer care by allowing deep collaboration between life sciences companies and oncology providers.

Segmentation of Cancer Registry Software Market-
By Software Type
• Standalone Software
• Integrated Software
By Database
• Public data
• Commercial data
By Deployment Model
• Cloud-based
• On-premises
By Functionality
• Cancer reporting to meet federal regulations.
• Patient care management
• Product outcome evaluation
• Medical research and clinical studies
By End-User-
• Government organization and third-party administrator
• Hospitals and medical practices
• Research centers
• Pharmaceutical, Biotechnology companies & medical device companies
• Private players
• Research centers
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.